This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
US and European Interventional Oncology Devices Market Assessment for Breast Cancer, Forecast to 2020
US and European Interventional Oncology Devices Market Assessment for Breast Cancer, Forecast to 2020
Improving Treatment Efficacy through Minimally Invasive Interventions is Driving the Demand for Interventional Procedures
RELEASE DATE
17-Sep-2019
17-Sep-2019
REGION
North America
North America
Research Code: MD8F-01-00-00-00
SKU: HC03218-NA-MR_23603
$4,950.00
In stock
SKU
HC03218-NA-MR_23603
Description
The research service provides an overview of the interventional oncology devices market for breast cancer in big five countries in Europe and in the United States. The study provides a four-year forecast from 2016 to 2020. The unique value of this study is that it provides insights gathered from more than 100 end users, including Interventional radiologists, interventional oncologists, and breast surgeons. The segments include ablation devices (primarily radiofrequency, cryo, and microwave), high-intensity–focused ultrasound (HIFU), and embolization devices, which include microcatheters, balloon catheter, microspheres, radioembolization spheres, PVA particles, embolic coils, chemo-embolization, gelatin sponge, bioabsorbable products, and drug-eluting beads.
Breast cancer surgical treatment has evolved from the days of the radical mastectomy to breast conservation surgery. However, over the last 5 years, there has been a stipulated increase in adoption for percutaneous treatment modalities for breast cancer instead of surgery. These modalities include cryoablation, radiofrequency ablation, microwave ablation, laser ablation, and ultrasound ablation. There are also the newest kinds of HIFU and embolization techniques that are used to treat tumors with precision. The biggest advantage is that most of these procedures are outpatient procedure and require minimal time for conducting the procedure. These segments are changing the dynamics of cancer therapies. Hospitals and manufacturers are interested in knowing the adoption potential of various products across different applications of cancer such as lung, liver, and breast cancers. This study focuses only on breast cancer. It is interesting to note that breast cancer has adoption of these interventions despite established care treatment paradigm. The biggest drawback and concern for this market is lack of reimbursement and insufficient clinical data to increase the scalability of the adoption of these procedures. However, interestingly, the adoption has been seen in a significant way for select anatomies of cancer, and this likely to drive the growth across all other cancer types too in the short term.
This study provides infrastructure details, procedure statistics, revenue forecasts, and competitive analysis across countries. The geographic areas covered in the study include the US, Germany, France, Italy, Spain and the UK. These regions have been on focus primarily because of the increased awareness of benefits of the adoption of these technologies and their ability to spend on new technologies and training for the surgeons to use the same. The base year for the study is 2017 and revenue forecasts have been provided until 2020.
Table of Contents
Executive Summary—Interventional Oncology Devices Market for Breast Cancer
Research Scope and Segmentation
Infrastructure Summary
Ablation Devices Market for Breast Cancer—Overview
Ablation Procedure and Market for Breast Cancer—Comparison of Europe and US
Ablation Procedure and Market Breast Cancer—Comparison of Europe and US (continued)
Radiofrequency Ablation Device Market for Breast Cancer—Comparison of Europe and US
Cryoablation Procedure and Market Comparison—Europe and US
Microwave Ablation Devices for Breast Cancer—Comparison of Europe and US
Ablation Devices Market for Breast Cancer—Europe and US Market Summary
HIFU Devices Market Overview
Embolization Devices Market Overview
Total HIFU and Embolization Devices Market for Breast Cancer—Comparison of Europe and US
Overview of Resources and Facilities
Total Interventional Procedures for All Cancer Versus Breast Cancer Procedures by Ablation
Total Breast Cancer Procedures by Type of Radiation Therapy and Image-guided Modalities
Total Breast Cancer Procedures by Type of Radiation Therapy and Image-guided Modalities (continued)
Ablation Devices Market for All Cancers and Breast Cancer in US
Competitive Analysis for Ablation Devices Market for Breast Cancer in US
HIFU Devices Market for All Cancer and Breast Cancer in US
Embolization Devices Market for All Cancer and Breast Cancer in US
Competitive Analysis for Embolization Devices Market for Breast Cancer in US
Factors Influencing Ablation Device Adoption in Clinical Settings
Factors Influencing Adoption of Interventional Devices
Product Price Trends and Impact on Procurement
Product Price Trends and Impact on Procurement (continued)
Service Capabilities and Offerings by Manufacturers
Patient Referral Trends and Medical Conferences
Overview of Resources and Facilities
Total Interventional Procedures for All Cancer Versus Breast Cancer Procedures by Ablation Devices
Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities
Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities (continued)
Ablation Market for All Cancer and Breast Cancer in UK
Competitive Analysis for Ablation Devices Market for Breast Cancer in UK
HIFU Devices Market Analysis and Competitive Landscape in the UK
Embolization Market Analysis and Competitive Landscape in UK
Factors Influencing Ablation Device Adoption in Clinical Settings
Factors Influencing Interventional Device Adoption in Clinical Settings
Product Price Trends and Impact on Procurement
Product Price Trends and Impact on Procurement (continued)
Service Capabilities and Offerings by Manufacturers
Patient Referral Trends and Medical Conferences
Overview of Resources and Facilities
Total Interventional Procedures for All Cancer Versus Breast Cancer Procedures by Ablation
Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities
Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities (continued)
Ablation Devices Market for All Cancer and Breast Cancer in UK
Competitive Analysis for Ablation Market for Breast Cancer in France
HIFU Devices Market Analysis and Competitive Landscape in the France
HIFU Devices Market Analysis and Competitive Landscape in France
Factors Influencing Ablation Device Adoption in Clinical Settings
Factors Influencing Interventional Device Adoption in Clinical Settings
Product Price Trends and Impact on Procurement
Product Price Trends and Impact on Procurement (continued)
Service Capabilities and Offerings by Manufacturers
Patient Referral Trends and Medical Conferences
Overview of Resources and Facilities
Total Interventional Procedures for All Cancer Versus Breast Cancer Procedures by Ablation
Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities
Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities (continued)
Ablation Market for All Cancer and Breast Cancer in Germany
Competitive Analysis for Ablation Devices Market for Breast Cancer in Germany
HIFU Devices Market Analysis and Competitive Landscape in the Germany
Embolization Devices Market Analysis and Competitive Landscape in Germany
Factors Influencing Ablation Device Adoption in Clinical Settings
Factors Influencing Interventional Device Adoption in Clinical Settings
Product Price Trends and Impact on Procurement
Product Price Trends and Impact on Procurement (continued)
Service Capabilities and Offerings by Manufacturers
Patient Referral Trends and Medical Conferences
Overview of Resources and Facilities
Total Interventional Procedures for All Cancer Versus Breast Cancer Procedures by Ablation
Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities
Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities (continued)
Ablation Market for All Cancer and Breast Cancer in Italy
Competitive Analysis for Ablation Devices Market for Breast Cancer in Italy
HIFU Market Analysis and Competitive Landscape in Italy
Embolization Devices Market Analysis and Competitive Landscape in Italy
Factors Influencing Ablation Device Adoption in Clinical Settings
Factors Influencing Interventional Device Adoption in Clinical Settings
Product Price Trends and Impact on Procurement
Product Price Trends and Impact on Procurement (continued)
Service Capabilities and Offerings by Manufacturers
Patient Referral Trends and Medical Conferences
Overview of Resources and Facilities
Total Interventional Procedures for All Cancer Versus Breast Cancer Procedures by Ablation
Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities
Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities (continued)
Ablation Market for All Cancer and Breast Cancer in Spain
Competitive Analysis for Ablation Market for Breast Cancer in Spain
HIFU Devices Market Analysis and Competitive Landscape in Spain
Embolization Devices Market Analysis and Competitive Landscape in Spain
Factors Influencing Ablation Device Adoption in Clinical Settings
Factors Influencing Interventional Device Adoption in Clinical Settings
Product Price Trends and Impact on Procurement
Product Price Trends and Impact on Procurement (continued)
Service Capabilities and Offerings by Manufacturers
Patient Referral Trends and Medical Conferences
Growth Opportunity—Collaborations and Partnerships from Vendors
Strategic Imperatives
The Last Word—3 Big Predictions
Legal Disclaimer
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
The research service provides an overview of the interventional oncology devices market for breast cancer in big five countries in Europe and in the United States. The study provides a four-year forecast from 2016 to 2020. The unique value of this study is that it provides insights gathered from more than 100 end users, including Interventional radiologists, interventional oncologists, and breast surgeons. The segments include ablation devices (primarily radiofrequency, cryo, and microwave), high-intensity–focused ultrasound (HIFU), and embolization devices, which include microcatheters, balloon catheter, microspheres, radioembolization spheres, PVA particles, embolic coils, chemo-embolization, gelatin sponge, bioabsorbable products, and drug-eluting beads.
Breast cancer surgical treatment has evolved from the days of the radical mastectomy to breast conservation surgery. However, over the last 5 years, there has been a stipulated increase in adoption for percutaneous treatment modalities for breast cancer instead of surgery. These modalities include cryoablation, radiofrequency ablation, microwave ablation, laser ablation, and ultrasound ablation. There are also the newest kinds of HIFU and embolization techniques that are used to treat tumors with precision. The biggest advantage is that most of these procedures are outpatient procedure and require minimal time for conducting the procedure. These segments are changing the dynamics of cancer therapies. Hospitals and manufacturers are interested in knowing the adoption potential of various products across different applications of cancer such as lung, liver, and breast cancers. This study focuses only on breast cancer. It is interesting to note that breast cancer has adoption of these interventions despite established care treatment paradigm. The biggest drawback and concern for this market is lack of reimbursement and insufficient clinical data to increase the scalability of the adoption of these procedures. However, interestingly, the adoption has been seen in a significant way for select anatomies of cancer, and this likely to drive the growth across all other cancer types too in the short term.
This study provides infrastructure details, procedure statistics, revenue forecasts, and competitive analysis across countries. The geographic areas covered in the study include the US, Germany, France, Italy, Spain and the UK. These regions have been on focus primarily because of the increased awareness of benefits of the adoption of these technologies and their ability to spend on new technologies and training for the surgeons to use the same. The base year for the study is 2017 and revenue forecasts have been provided until 2020.
| No Index | No |
|---|---|
| Podcast | No |
| Author | Sowmya Rajagopalan |
| Industries | Healthcare |
| WIP Number | MD8F-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9A47-B1,9A48-B1,9A4B-B1 |